US Broker Ratings

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: Unveiling a 37.61% Upside Potential in the Biotech Arena

Xenon Pharmaceuticals Inc. (XENE) is making waves in the biotechnology sector with its significant focus on neuroscience, aiming to address neurological and psychiatric disorders. Headquartered in..

Mirum Pharmaceuticals (MIRM) Stock Analysis: Robust Revenue Growth and Strong Buy Ratings Capture Investor Attention

Mirum Pharmaceuticals, Inc. (MIRM), a pioneer in the biotechnology sector, has been making waves with its innovative approach to tackling rare and orphan diseases. With a..

Envista Holdings Corporation (NVST) Stock Analysis: Unveiling a 11.43% Potential Upside for Investors

Envista Holdings Corporation (NYSE: NVST), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, is gaining attention from investors due..

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: Exploring a 68% Upside Potential

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) has been capturing the attention of investors with its promising outlook in the biotechnology sector. The company, headquartered in Coral Gables,..

Metsera, Inc. (MTSR) Stock Analysis: Discover the 4.78% Upside Potential in the Biotechnology Sector

Metsera, Inc. (NASDAQ: MTSR) is making waves in the biotechnology sector with its innovative approach to combating obesity and related diseases. As a clinical-stage company based..

Apogee Therapeutics, Inc. (APGE) Investor Outlook: Exploring the 72.52% Potential Upside

Apogee Therapeutics, Inc. (NASDAQ: APGE), a burgeoning name in the biotechnology sector, presents an intriguing opportunity for investors keen on the healthcare industry. With a current..

Haemonetics Corporation (HAE) Stock Analysis: A Closer Look at Growth Potential Amid Market Volatility

Haemonetics Corporation (NYSE: HAE), a prominent player in the healthcare sector specializing in medical devices, has recently caught the attention of investors. With a market capitalization..

Perrigo Company plc (PRGO) Stock Analysis: Exploring a 61% Potential Upside Amid Solid Dividend Yield

Perrigo Company plc (PRGO) stands at a pivotal intersection for investors seeking opportunities in the healthcare sector, specifically within the niche of specialty and generic drug..

ACADIA Pharmaceuticals (ACAD): Investor Outlook on Potential 43.78% Upside

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a prominent player in the biotechnology sector, is garnering significant investor attention owing to its focus on developing treatments for central..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: A Look at Its 49% Revenue Growth and Potential Upside

Alignment Healthcare, Inc. (NASDAQ: ALHC) presents an intriguing investment opportunity within the healthcare sector, particularly in the specialized industry of healthcare plans. This Orange, California-based company..

Arcellx, Inc. (ACLX) Stock Analysis: A Promising Biotech Play with Significant Upside Potential

For investors with a keen interest in the biotechnology sector, Arcellx, Inc. (NASDAQ: ACLX) presents an intriguing opportunity. As a healthcare company specializing in innovative immunotherapies,..

Akero Therapeutics, Inc. (AKRO) Stock Analysis: Exploring a 20% Upside Potential in Biotech

Akero Therapeutics, Inc. (NASDAQ: AKRO), a promising player in the biotechnology sector, is making waves with its innovative approach to treating serious metabolic diseases. Headquartered in..

Avidity Biosciences, Inc. (RNA) Stock Analysis: Exploring a 36.85% Potential Upside in Innovative RNA Therapeutics

Avidity Biosciences, Inc. (NASDAQ: RNA) is making waves in the biotechnology sector with its innovative approach to RNA therapeutics. Based in San Diego, California, Avidity is..

Axsome Therapeutics (AXSM) Stock Analysis: Unpacking a Potential 45% Upside in Biotech

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is capturing the attention of investors seeking opportunities in the dynamic biotechnology sector. With a robust pipeline of therapies targeting central..

Elanco Animal Health (ELAN) Stock Analysis: Growth Potential and Market Dynamics

Elanco Animal Health Incorporated (NYSE: ELAN) stands at the crossroads of innovation and animal welfare. With a market capitalization of $9.82 billion, this healthcare sector player..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring a 57% Potential Upside Amidst Healthcare Innovations

In the dynamic realm of healthcare, Lantheus Holdings, Inc. (NASDAQ: LNTH) emerges as a compelling player, particularly for investors seeking opportunities in the specialty and generic..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Exploring a 72.68% Potential Upside

Inspire Medical Systems, Inc. (NASDAQ: INSP), a pivotal player in the healthcare sector, particularly within the medical devices industry, is catching the eye of investors with..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Eyeing a 6.84% Potential Upside in the Healthcare Sector

Bausch + Lomb Corporation (NYSE: BLCO), a stalwart in the ophthalmic industry, has long been a beacon for innovation in eye health. With a market capitalization..

Nuvalent, Inc. (NUVL) Stock Analysis: Exploring a 32% Upside Potential with Strong Buy Ratings

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, is capturing investor attention due to its promising drug pipeline and notable upside potential...

Rhythm Pharmaceuticals (RYTM) Stock Analysis: A Biotech Powerhouse with 17% Upside Potential

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is a compelling player in the biotechnology sector, specializing in the treatment of rare neuroendocrine diseases. With its lead product, IMCIVREE..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds